{"id":"clopidogrel-cilostazol","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Palpitations"},{"rate":null,"effect":"Tachycardia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Clopidogrel is a P2Y12 receptor antagonist that irreversibly blocks ADP-induced platelet aggregation, while cilostazol is a phosphodiesterase-3 inhibitor that increases cAMP levels in platelets, promoting vasodilation and further inhibiting platelet aggregation. Together, they provide dual antiplatelet effects to prevent clot formation.","oneSentence":"This combination of clopidogrel and cilostazol works by inhibiting platelet aggregation through different pathways to reduce thrombotic events.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:39:54.700Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Secondary prevention of thrombotic events in patients with coronary artery disease or cerebrovascular disease"},{"name":"Peripheral arterial disease"}]},"trialDetails":[{"nctId":"NCT06757764","phase":"PHASE4","title":"The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-07-10","conditions":"Cerebral Infarction, Stenosis Artery","enrollment":2340},{"nctId":"NCT07495969","phase":"NA","title":"Randomized Clinical Trial of Endovascular Recanalization for Symptomatic Non-Acute Intracranial Artery Occlusion（REPAIR）","status":"NOT_YET_RECRUITING","sponsor":"Feng Gao","startDate":"2026-04-01","conditions":"Symptomatic Non-acute Intracranial Artery Occlusion, Ischemic Stroke","enrollment":286},{"nctId":"NCT07180472","phase":"PHASE4","title":"Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Chengdu Medical College","startDate":"2025-09-20","conditions":"Cerebral Small Vessel Disease","enrollment":632},{"nctId":"NCT06591377","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-08-10","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06591338","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-09-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06983795","phase":"","title":"Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study","status":"NOT_YET_RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-07","conditions":"Ischemic Stroke, Patent Foramen Ovale","enrollment":1000},{"nctId":"NCT06715007","phase":"","title":"Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-12-20","conditions":"Stroke, Ischemic, Small Vessel Cerebrovascular Disease, White Matter Hyperintensity","enrollment":300},{"nctId":"NCT04522102","phase":"PHASE3","title":"Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase","status":"COMPLETED","sponsor":"The George Institute for Global Health, China","startDate":"2021-09-03","conditions":"Intracerebral Hemorrhage","enrollment":80},{"nctId":"NCT03062319","phase":"PHASE4","title":"Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis","status":"TERMINATED","sponsor":"National Hospital Organization Osaka National Hospital","startDate":"2017-04-06","conditions":"Ischemic Stroke, Atrial Fibrillation, Atherothrombosis","enrollment":321},{"nctId":"NCT06591390","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-02-09","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06591299","phase":"PHASE3","title":"Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-04-15","conditions":"Ischemic Stroke","enrollment":870},{"nctId":"NCT06591351","phase":"PHASE3","title":"Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":"Ischemic Stroke","enrollment":870},{"nctId":"NCT06242132","phase":"PHASE3","title":"Clopidogrel Versus Cilostazol in Ischemic Stroke","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2022-06-01","conditions":"Ischemic Stroke","enrollment":870},{"nctId":"NCT06591312","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06242145","phase":"PHASE3","title":"Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2023-01-01","conditions":"Ischemic Stroke","enrollment":580},{"nctId":"NCT06561867","phase":"PHASE3","title":"Ticagrelor Versus Cilostazol in Ischemic Stroke","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-08-30","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06202755","phase":"PHASE3","title":"Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-03-30","conditions":"Ischemic Stroke","enrollment":580},{"nctId":"NCT06522113","phase":"PHASE4","title":"Cilostazol and Aspirin in Stroke and TIA","status":"COMPLETED","sponsor":"Incheon St.Mary's Hospital","startDate":"2019-07-18","conditions":"Ischemic Stroke, TIA","enrollment":378},{"nctId":"NCT06402747","phase":"PHASE4","title":"Clopidogrel Versus Cilostazol on Vessels","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2024-04-16","conditions":"Type 2 Diabetes, Atherosclerosis","enrollment":120},{"nctId":"NCT06058130","phase":"NA","title":"Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-09-29","conditions":"Acute Ischemic Stroke, Atrial Fibrillation, Stenosis, Carotid","enrollment":2171},{"nctId":"NCT06053021","phase":"NA","title":"Antiplatelet Therapy for AIS Patients With Thrombocytopenia","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-09-15","conditions":"Acute Ischemic Stroke, Thrombocytopenia","enrollment":1200},{"nctId":"NCT03581409","phase":"PHASE4","title":"Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2018-10-24","conditions":"Aneurysm, Cerebral, Endovascular Procedures","enrollment":198},{"nctId":"NCT02554721","phase":"PHASE1","title":"Pharmacodynamic Study of Cilostazol in Healthy Volunteers","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"2015-08","conditions":"Healthy","enrollment":77},{"nctId":"NCT04999293","phase":"","title":"Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Dalian Medical University","startDate":"2021-07-20","conditions":"Platelet Aggregation Inhibitors, Dual Anti-Platelet Therapy, Aged","enrollment":1505},{"nctId":"NCT02983214","phase":"PHASE4","title":"Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?","status":"COMPLETED","sponsor":"University of Ioannina","startDate":"2016-11","conditions":"Ischemic Stroke, Peripheral Artery Disease, Diabetes Mellitus, Type 2","enrollment":826},{"nctId":"NCT01955200","phase":"PHASE4","title":"OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial","status":"COMPLETED","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2013-10-05","conditions":"Coronary Artery Disease","enrollment":1724},{"nctId":"NCT04501900","phase":"PHASE4","title":"The 3 Years vs 1 Year DAPT After XINSORB BRS Implantation","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2020-10","conditions":"Cardiovascular Diseases","enrollment":2106},{"nctId":"NCT04407312","phase":"PHASE4","title":"Cilostazol and Endothelial Progenitor Cell","status":"UNKNOWN","sponsor":"Gyeongsang National University Hospital","startDate":"2016-01-01","conditions":"Myocardial Infarction, Acute","enrollment":60},{"nctId":"NCT01261832","phase":"PHASE4","title":"Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients","status":"UNKNOWN","sponsor":"Korea University Guro Hospital","startDate":"2011-07","conditions":"Acute Myocardial Infarction","enrollment":951},{"nctId":"NCT02101411","phase":"","title":"Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)","status":"COMPLETED","sponsor":"Taipei City Hospital","startDate":"2015-01-01","conditions":"PRU(Platelet Reactivity Unit), APT(Antiplatelet Therapy), HOTPR(High on Treat Platelet Reactivity)","enrollment":334},{"nctId":"NCT03190005","phase":"","title":"Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)","status":"COMPLETED","sponsor":"Taipei City Hospital","startDate":"2017-01-01","conditions":"Stable Angina","enrollment":35},{"nctId":"NCT02101437","phase":"NA","title":"The Relationship of Platelet Micro-RNA Expression and Platelet Reactivity in Patients Under Clopidogrel or Ticagrelor Treatment","status":"COMPLETED","sponsor":"Taipei City Hospital","startDate":"2014-01","conditions":"PRU, miRNA","enrollment":175},{"nctId":"NCT01995370","phase":"PHASE4","title":"Cilostazol Stroke Prevention Study for Antiplatelet Combination","status":"COMPLETED","sponsor":"Japan Cardiovascular Research Foundation","startDate":"2013-12-13","conditions":"Noncardioembolic Cerebral Infarction","enrollment":1884},{"nctId":"NCT02829151","phase":"PHASE4","title":"Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2017-02-21","conditions":"Critical Limb Ischemia","enrollment":390},{"nctId":"NCT03471169","phase":"PHASE1","title":"Individualized Antithrombotic Therapy for Patients With Ischemic Cerebrovascular Disease","status":"UNKNOWN","sponsor":"Xuanwu Hospital, Beijing","startDate":"2017-04-01","conditions":"Cerebrovascular Disease","enrollment":3500},{"nctId":"NCT01570803","phase":"NA","title":"Efficacy Between Different Two Self-Expanding Nitinol Stents For The Atherosclerotic Femoro-Popliteal Arterial Disease","status":"WITHDRAWN","sponsor":"Korea University Guro Hospital","startDate":"2013-01","conditions":"Arterial Disease, Atherosclerosis","enrollment":""},{"nctId":"NCT01359423","phase":"NA","title":"Comparison of Primary Long Full Coverage Stenting vs Primary Short Spot Stenting for Long Femoropopliteal Artery Disease.","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2011-09-26","conditions":"Claudication","enrollment":89},{"nctId":"NCT01779401","phase":"NA","title":"Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients","status":"COMPLETED","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2012-09","conditions":"Coronary Heart Disease","enrollment":1078},{"nctId":"NCT01192724","phase":"PHASE4","title":"Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2010-03","conditions":"Coronary Artery Disease","enrollment":630},{"nctId":"NCT01267734","phase":"PHASE4","title":"Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2010-06","conditions":"Coronary Heart Disease","enrollment":3750},{"nctId":"NCT00776828","phase":"PHASE4","title":"The Efficacy of CILostazol ON Ischemic Complications After DES Implantation","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2006-11","conditions":"Coronary Artery Disease","enrollment":960},{"nctId":"NCT01354808","phase":"PHASE4","title":"ACCEL-LOADING-ACS Study","status":"COMPLETED","sponsor":"Gyeongsang National University Hospital","startDate":"2010-07","conditions":"Platelet Aggregation Inhibitors, Anti-inflammatory Agent, Myocardial Reperfusion Injury","enrollment":220},{"nctId":"NCT01482117","phase":"NA","title":"The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers","status":"COMPLETED","sponsor":"Inje University","startDate":"2011-11","conditions":"Interaction","enrollment":28},{"nctId":"NCT01653600","phase":"PHASE4","title":"Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease","status":"UNKNOWN","sponsor":"Korea University Guro Hospital","startDate":"2012-09","conditions":"Peripheral Arterial Disease, Atherosclerosis","enrollment":346},{"nctId":"NCT01094457","phase":"PHASE4","title":"Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation","status":"COMPLETED","sponsor":"Shenyang Northern Hospital","startDate":"2009-03","conditions":"Acute Coronary Syndromes, Percutaneous Coronary Intervention, Clopidogrel Low Responsiveness","enrollment":840},{"nctId":"NCT01012193","phase":"PHASE4","title":"Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism","status":"COMPLETED","sponsor":"Gyeongsang National University Hospital","startDate":"2008-01","conditions":"Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":134},{"nctId":"NCT01328470","phase":"PHASE4","title":"Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Kyunghee University Medical Center","startDate":"2009-09","conditions":"Chronic Kidney Disease, Stable Angina","enrollment":85},{"nctId":"NCT00130039","phase":"PHASE4","title":"Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2005-08","conditions":"Cerebral Infarction, Atherosclerosis","enrollment":457},{"nctId":"NCT00915733","phase":"PHASE4","title":"Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism","status":"COMPLETED","sponsor":"Gyeongsang National University Hospital","startDate":"2009-05","conditions":"Myocardial Infarction","enrollment":80},{"nctId":"NCT00404781","phase":"PHASE4","title":"Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"Shenyang Northern Hospital","startDate":"2006-06","conditions":"Ischemic Heart Disease, Acute Coronary Syndromes","enrollment":305},{"nctId":"NCT00938522","phase":"PHASE4","title":"Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2009-07","conditions":"Angioplasty, Transluminal, Percutaneous Coronary","enrollment":400},{"nctId":"NCT00891670","phase":"PHASE3","title":"Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism","status":"UNKNOWN","sponsor":"Gyeongsang National University Hospital","startDate":"2009-05","conditions":"Coronary Artery Stenosis, Maximal Platelet Aggregation, Late Platelet Aggregation","enrollment":80},{"nctId":"NCT00620646","phase":"NA","title":"The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2008-02","conditions":"Clopidogrel Non-Responsiveness","enrollment":80},{"nctId":"NCT00300339","phase":"PHASE2","title":"Mixed Antagonist of Serotonin for Claudication Optimal Therapy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-02","conditions":"Intermittent Claudication","enrollment":599}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":39,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Plavix","pletaal"],"phase":"marketed","status":"active","brandName":"Clopidogrel, cilostazol","genericName":"Clopidogrel, cilostazol","companyName":"Kyunghee University Medical Center","companyId":"kyunghee-university-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination of clopidogrel and cilostazol works by inhibiting platelet aggregation through different pathways to reduce thrombotic events. Used for Secondary prevention of thrombotic events in patients with coronary artery disease or cerebrovascular disease, Peripheral arterial disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}